2023 - Present
ArtCart+ Characterization and Optimization Studies
Enhancing the Articular Cartilage Paste Graft (ArtCart) surgical technique, with support from the California Institute for Regenerative Medicine (CIRM), to improve graft fixation, cell viability, and cartilage regeneration with the goal of developing a one-step, affordable, and accessible OA treatment.
2024 - Present
ArtCart+ Equine Study: Definitive Efficacy Phase
Evaluating an enhanced version of the Articular Cartilage Paste Graft (ArtCart) surgical technique in an equine joint model to improve cartilage regeneration and graft fixation, advance treatment for veterinary patients, and generate essential evidence for future human clinical improvements. mass and health.
2022 - Present
Characterization of Orthobiologic Injections [SD2]
Comparing leading orthobiologic injections for joint pain and inflammation to determine which therapies provide the safest, most effective, and longest-lasting outcomes for patients with sports injuries and arthritis. Presented at ORS 2025, ISAKOS 2025
2022 - Present
Alpha-Gal Nanoparticle Study at the University of Illinois, Urbana-Champaign (UIUC)
Investigating whether adding the Alpha-Gal carbohydrate to augment the Articular Cartilage Paste Graft (ArtCart) procedure can stimulate a stronger healing response and produce more effective cartilage regeneration in arthritic joints through a novel molecular approach.
2024 - Present
Use of Testosterone to Reduce Post-Surgical Muscle Loss: Clinical Trial
Building on a completed 15-patient pilot demonstrating feasibility and safety, this study will test whether short-term, long-acting injectable testosterone can protect against muscle loss after knee surgery. MuscleSound, Inc. technology will provide detailed ultrasound assessments of muscle mass and health.